Cytogénétique et génétique moléculaire dans la myélofibrose avec métaplasie myéloïde et dans la polyglobulie de Vaquez = Cytogenetics and molecular genetics in myelofibrosis with myeloid metaplasia and polycythemia VeraROCHE-LESTIENNE, C; ANDRIEUX, J.Pathologie et biologie. 2007, Vol 55, Num 1, pp 49-55, issn 0369-8114, 7 p.Article

Les formes familiales des syndromes myéloprolifératifs Philadelphie-négatifs: caractéristiques cliniques et moléculaires = Familial Philadelphia-negative myeloproliferative disorders: clinical and molecular characteristicsBELLANNECHANTELOT, Christine; SAINT-MARTIN, Cécile; MALAK, Sandra et al.Hématologie (Montrouge). 2011, Vol 17, Num 5, pp 331-341, issn 1264-7527, 11 p.Article

Complications pulmonaires non infectieuses des maladies myéloprolifératives et des syndromes myélodysplasiques = Non-infectious pulmonary complications of myelodysplastic syndromes and chronic myeloproliferative disordersLAMOUR, C; BERGERON, A.Revue des maladies respiratoires. 2009, Vol 26, Num 6, pp 655-665, issn 0761-8425, 11 p.Article

Syndromes myéloprolifératifs et thrombosesGRIFFON, Christophe; STEPHAN, Dominique.MT. Médecine thérapeutique. 2009, Vol 15, Num 1, pp 15-24, issn 1264-6520, 10 p.Article

Glomérulopathies associées aux syndromes myéloprolifératifs = Myeloproliferative neoplasms related glomerulopathyPAULE, R; PONSOYE, M; GUEUTIN, V et al.La Revue de médecine interne (Paris). 2013, Vol 34, Num 6, pp 369-372, issn 0248-8663, 4 p.Article

Complications pulmonaires non infectieuses des maladies myéloprolifératives et des syndromes myélodysplasiques = Non-infectious pulmonary complications of myelodysplastic syndromes and chronic myeloproliferative disordersLAMOUR, C; BERGERON, A.Revue des maladies respiratoires. 2010, Vol 27, pp 43-53, issn 0761-8425, 11 p., MONOArticle

Conduite à tenir devant une thrombocytose = Management of adults presenting with a thrombocytosisVIALLARD, J.-F.La Revue de médecine interne (Paris). 2010, Vol 31, issn 0248-8663, S333-S338, SUP3Conference Paper

Syndromes myéloprolifératifs « Philadelphie négatif » et mutation JAK2V617F: étude des 15 premiers cas ayant bénéficié de cette recherche au Togo = Myeloproliferative disorders Philadelphia negative and JAK2V617F mutation: study of 15 cases in TogoPADARO, Essohana; AGBETIAFA, Kossi; MESSANH DELAGNON KUEVIAKOE, Irénée et al.Annales de biologie clinique (Paris). 2012, Vol 70, Num 5, pp 591-594, issn 0003-3898, 4 p.Article

Syndromes myéloprolifératifs chromosome Philadelphie-négatifs = Minimal residual disease in chromosome Philadelphia-negative myeloproliferative neoplasmsWEMEAU, M; KILADJIAN, J. J.Correspondances en onco-hématologie. 2012, Vol 7, Num 4, pp 213-216, issn 1954-4820, 4 p.Article

Hypertension artérielle pulmonaire et hémopathies malignes = Pulmonary arterial hypertension and malignant hematologic disordersCOSTELLO, R.La Revue de médecine interne (Paris). 2010, Vol 31, Num 9, pp 621-625, issn 0248-8663, 5 p.Article

Rationnel et modalités de prescription du ruxolitinib dans les myélofibroses = Ruxolitinib prescription in myelofibrosisLEMAL, Richard; ROBIN, Marie; RAVINET, Aurélie et al.Bulletin du cancer. 2013, Vol 100, Num 9, pp 897-902, issn 0007-4551, 6 p.Article

Myeloproliferative disordersLEVINE, Ross L; GILLILAND, D. Gary.Blood. 2008, Vol 112, Num 6, pp 2190-2198, issn 0006-4971, 9 p.Article

Transient myeloproliferative disorderMOIZ, Bushra; SHAFLQ, Maria.Blood. 2012, Vol 120, Num 24, issn 0006-4971, p. 4672Article

Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative diseaseAGARWAL, Anupriya; BUMM, Thomas G. P; DEININGER, Michael W et al.Blood. 2008, Vol 112, Num 5, pp 1960-1970, issn 0006-4971, 11 p.Article

Myeloproliferative neoplasmsPUBLICOVER, Amy; MEDD, Patrick.Clinical medicine. 2013, Vol 13, Num 2, pp 188-192, issn 1470-2118, 5 p.Article

Role of Additional Novel Therapies in Myeloproliferative NeoplasmsFISKUS, Warren; GANGULY, Siddhartha; KAMBHAMPATI, Suman et al.Hematology/oncology clinics of North America. 2012, Vol 26, Num 5, issn 0889-8588, vii, 959-980 [22 p.]Article

Possible new LNK mutations in myeloproliferative neoplasmsHA, Jung-Sook; JEON, Dong-Seok.American journal of hematology. 2011, Vol 86, Num 10, pp 866-868, issn 0361-8609, 3 p.Article

Myeloproliferative Neoplasms: Molecular Pathophysiology, Essential Clinical Understanding, and Treatment StrategiesTEFFERI, Ayalew; VAINCHENKER, William.Journal of clinical oncology. 2011, Vol 29, Num 5, pp 573-582, issn 0732-183X, 10 p.Article

Blood cell activation in myeloproliferative neoplasmsCERVANTES, Francisco; ARELLANO-RODRIGO, Eduardo; ALVAREZ-LARRAN, Alberto et al.Haematologica (Roma). 2009, Vol 94, Num 11, pp 1484-1488, issn 0390-6078, 5 p.Article

Molecular basis of myelodysplastic/myeloproliferative neoplasmsREITER, Andreas; INVERNIZZI, Rosangela; CROSS, Nicholas C. P et al.Haematologica (Roma). 2009, Vol 94, Num 12, pp 1634-1638, issn 0390-6078, 5 p.Article

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignanciesABDEL-WAHAB, Omar; MULLALLY, Ann; HUBERMAN, Kety et al.Blood. 2009, Vol 114, Num 1, pp 144-147, issn 0006-4971, 4 p.Article

Deregulated Intracellular Signaling by Mutated c-CBL in Myeloid NeoplasmsOGAWA, Seishi; SHIH, Lee-Yung; SUZUKI, Takahiro et al.Clinical cancer research (Print). 2010, Vol 16, Num 15, pp 3825-3831, issn 1078-0432, 7 p.Article

Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasmsQUINTAS-CARDAMA, Alfonso; VADDI, Kris; RUPAR, Mark et al.Blood. 2010, Vol 115, Num 15, pp 3109-3117, issn 0006-4971, 9 p.Article

Genotype-Phenotype Interactions in the Myeloproliferative NeoplasmsGODFREY, Anna L; GREEN, Anthony R.Hematology/oncology clinics of North America. 2012, Vol 26, Num 5, issn 0889-8588, vii, 993-1015 [23 p.]Article

Disordered Signaling in Myeloproliferative NeoplasmsANAND, Shubha; HUNTLY, Brian J. P.Hematology/oncology clinics of North America. 2012, Vol 26, Num 5, issn 0889-8588, vii-viii, 1017-1035 [20 p.]Article